Looking for guidance on who may benefit from calcitonin gene-related peptide (CGRP)-targeted therapies for migraine prevention? Unsure which migraine preventive therapy may be best for your patient? In this CliniClip activity, Drs Jessica Ailani and Susan Hutchinson use real-world patient scenarios to share their expert insights on who may benefit from a CGRP-targeted therapy and highlight when a small molecule or a monoclonal antibody may be appropriate for migraine prevention.

Click the link below to access the course:

https://cmepreview.healio.com/neurology/20220207/incorporating-new-therapeutic-tools-for-migraine-prevention-an-expert-guided-discussion/cme-overview